WNK1 knockdown in primary glioma cells results in attenuated phosphorylation of NKCC1, the ubiquitously expressed ion co-transporter, in response to the chemotherapeutic drug temozolomide, reducing glioma cell migration (Garzon-Muvdi et al., 2012). The gene discussed is WNK1; the disease is central nervous system cancer.